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ABSTRACT 
 
Background: While illicit drug use is prevalent among gay and bisexual men (GBM) in Australia, 
little is known about the relationship between injecting drug use and sexual risk in this group.  
Methods: The Following Lives Undergoing Change (FLUX) study is a national, online prospective 
observational cohort investigating drug use among Australian GBM. Men living in Australia who 
were aged 16.5 years or older, identified as gay or bisexual or had sex with at least one man in the last 
year were eligible to enrol. We used univariate and multivariate log-binomial regression methods to 
examine associations between socio-demographic and behavioural characteristics and recent (last six 
months) injecting.  
Results: Of 1,995 eligible respondents, 206 (10.3%) reported ever injecting drugs and 93 (4.7%) had 
injected recently. Crystal methamphetamine was the drug most commonly recently injected (91.4%), 
followed by methamphetamine powder (9.7%). Only 16 (17.2%) men who recently injected drugs 
reported injecting weekly or more frequently but one in ten (N=8, 8.6%) reported recent receptive 
syringe sharing. Recent injecting was associated with lifetime use of more drug classes (adjusted 
prevalence ratio (APR) = 1.31, 95% Confidence Interval (CI) 1.21-1.41), longer time since initiating 
party drug use (APR = 1.02, 95% CI 1.01-1.04),  greater numbers of sex partners (2-10 sex partners: 
APR = 3.44, 95% CI 1.45-8.20; >10 sex partners: APR = 3.21, 95% CI 1.30-7.92), group sex (APR = 
1.42, 95% CI 1.05-1.91) and condomless anal intercourse with casual partners (APR = 1.81, 95% CI 
1.34-2.43) in the last six months.  
Conclusions: Observed associations between injecting and sexual risk reflect a strong relationship 
between these practices among GBM. The intersectionality between injecting drug use and sex 
partying indicates a need to integrate harm reduction interventions for GBM who inject 
methamphetamine into sexual health services and targeted sexual health interventions into Needle and 
Syringe Programs.  
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INTRODUCTION 
Illicit drug use is prevalent among gay and bisexual men (GBM) in Australia. According to the 
Australian Gay Community Period Survey (GCPS), between 2004 and 2015, 57% to 72% of GBM 
reported illicit drug use in the last six months (Hull et al., 2015; Lea, Prestage, et al., 2013). Injecting 
drug use is more prevalent among GBM than among heterosexual people (Roxburgh, Lea, de Wit, & 
Degenhardt, 2016). In a 2013 nationally representative sample, 6.2% of participants who identified as 
lesbian, gay and bisexual (LGB) reported ever injecting drugs compared to 1.3% of heterosexual 
participants (Roxburgh et al., 2016). LGB participants constituted 2.7% of the sample (including 1.3% 
GBM and 1.4% lesbian and bisexual women) but represented 11.6% of ever drug injectors (Roxburgh 
et al., 2016). Between 2001 and 2009, 4.3% - 7.0% of participants in convenience samples recruited 
in the national GCPS reported injecting drugs in the last 6 months (Holt, Mao, Prestage, Zablotska, & 
de Wit, 2011). 
 
Previous studies indicate that many GBM use amyl nitrite, methamphetamine (including crystal 
methamphetamine) and oral erectile dysfunction medications (EDM) (Prestage, 2009) to enhance 
sexual pleasure and performance (McCabe, Hughes, Bostwick, West, & Boyd, 2009; Prestage, 
Grierson, Bradley, Hurley, & Hudson, 2009).  The GCPS was established in 1996 to monitor trends in 
sexual practices, drug use and testing practices related to HIV transmission among gay and other 
homosexually active men (Holt et al., 2016; Zablotska, Prestage, Middleton, Wilson, & Grulich, 
2010). Questions about the sharing of injecting equipment are not routinely asked. In the 2004 
Queensland GCPS, 95 respondents reported injecting drugs, of whom seven men (7.4%) had shared a 
needle or syringe in the previous six months (Hull et al., 2004). An online cross-sectional survey of 
474 Australian GBM conducted in 2013 found that among the 15.0% of respondents who reported 
injecting drug use in the previous six months, 8.5% reported receptive syringe sharing (RSS) and 
38.0% reported sharing ancillary injecting equipment (swabs, water ampoules) (Hopwood, Lea, & 
Aggleton, 2015). Unsafe injecting practices by GBM in the context of sex are of particular concern, 
because they may faciliate HIV transmission and, especially among  men living with HIV, hepatitis C 
virus (HCV) transmission (Alter, 2007; Ghanem et al., 2011). Drug use has been implicated in HIV 
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transmission via its association with high-risk sexual practices, particularly condomless anal 
intercourse among GBM (Bolding, Hart, Sherr, & Elford, 2006; Buchacz et al., 2005; Difranceisco, 
Ostrow, & Chmiel, 1996; Koblin et al., 2003; McCabe et al., 2009; Prestage, 2009; Prestage, 
Grierson, et al., 2009; Rawstorne, Digiusto, Worth, & Zablotska, 2007; Rusch, Lampinen, Schilder, & 
Hogg, 2004; Solomon, Kiang, Halkitis, Moeller, & Pappas, 2010). In Australia, 3.8% of new HIV 
infections are estimated to be among GBM who inject drugs, although the exposure cannot be 
precisely determined as sexual or injecting (The Kirby Institute, 2015).  
 
Despite the growing body of research on drug use among GBM, most studies of injecting drug use in 
this population have either been qualitative and thus unable to identify the correlates of injecting 
(Amaro, 2016; Dowsett, Wain, & Keys, 2005; Ellard, 2007; Slavin, 2004a, 2004b; Southgate & 
Hopwood, 1993, 2001) or have only collected incidental data about injecting. To better understand the 
factors associated with injecting drug use in this population and to elucidate their potential role in 
HIV and HCV transmission, we investigated the prevalence and correlates of recent injecting in a 
large prospective observational study specifically designed to examine drug use among GBM. Such 
findings will be of use to harm reduction, sexual health and gay men’s community organisations as 
they target and tailor their interventions for this population. 
 
METHODS 
Data source and measures 
The Following Lives Undergoing Change (FLUX) study is an ongoing online prospective 
observational cohort of Australian GBM which examines the prevalence and incidence of drug use 
and associated harms, and risk factors for uptake and changes in drug use over time. Baseline data 
were collected in 2014-2015 and the study protocol and procedure have been reported elsewhere 
(Hammoud et al., 2017). The study protocol was approved by the UNSW Human Research Ethics 
Committee (HC14075). Recruitment was conducted online using popular GBM ’dating’ sites and 
apps, and Facebook and at gay community events to reach a diverse sample of GBM across Australia. 
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Potential participants were directed to the study website for enrolment, and were not offered 
incentives to enroll. Eligible participants were men who were aged 16.5 years or older, and who 
identified as gay/homosexual or bisexual, or reported sexual contact with another man at least once in 
the last 12 months. Among those who visited the study website, completed the online consent form, 
then fulfilled the minimum data requirements for the online questionnaire, we selected those men who 
responded to questions about illicit drug use.  
 
A comprehensive self-completed questionnaire with approximately 200 questions was used to collect 
data on demographic characteristics; social and community engagement; HIV and HCV status; 
lifetime and recent (last six months) drug use (Degenhardt, Day, Gilmour, & Hall, 2005); pleasures 
and harms associated with drug use; sexual behaviour (Jin et al., 2009; Zablotska, Kippax, Grulich, 
Holt, & Prestage, 2011); stigma and mental health; attitudes to gay community and drug use; and 
access to and use of harm reduction resources.  
 
Socio-demographic characteristics included traditional confounding factors such as age (categorised 
into age groups 31-50 and >50 versus <30), education level, employment status (full-time/part-time 
employed/student versus unemployed (including participants who reported being on social security), 
and sexual identification (gay/homosexual versus other). Measures of gay community engagement 
included scales measuring the extent of community engagement and types of engagement (Kippax et 
al., 1998), specifically engagement with gay friends and with gay friends who use drugs. The score on 
social engagement with gay friends (range: one to nine) was constructed as a sum of scores on two 
questions: ‘How many of your friends are gay or homosexual men?’ (A five-point Likert scale: 1- 
none; 2 - a few; 3 - some; 4 -most and 5 - all) and ‘How much of your free time is spent with gay 
friends?’ (A four-point Likert scale: 1 - none; 2 - a little; 3 - some and 4 - a lot). The score on social 
engagement with gay friends who use drugs was created using the same approach and questions 
‘What proportion of your current gay friends use drugs?’ and ‘How much of your free time is spent 
with gay friends who use drugs?’ Mental health status, particularly depression and anxiety were 
measured using the Generalised Anxiety Disorder assessment scale (GAD7) (Spitzer, Kroenke, 
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Williams, & Lowe, 2006)
 
and the Patient Health Questionnaire (PHQ9) (Kroenke, Spitzer, & 
Williams, 2001). A score of five or above was used to indicate a presence of depression or anxiety. 
 
A list of ten psychoactive drugs was used to measure any use of each drug and lifetime and recent (in 
the last six months) injecting. This list included ‘party drugs’ (ecstasy, speed or methamphetamine 
(MA), crystal MA, cocaine, gamma-hydroxybutyrate (GHB), and ketamine (K)) and other drugs 
(heroin, lysergic acid diethylamide (LSD), marijuana and amyl nitrate). The concept of ‘party drugs’ 
reflects common usage within specific networks of gay men often referred to in the literature as club 
drugs or with respect to ‘circuit parties’ (Halkitis & Palamar, 2008; Halkitis, Palamar, & Mukherjee, 
2007; Morgenstern et al., 2009; Pappas & Halkitis, 2011). Time since first party drug use was 
measured in years and calculated by subtracting the participant’s age at first use of any party drug 
from their current age. 
 
The following variables were assessed: number of sexual partners in the last six months (0-1 versus 2-
10 and >10), condomless anal intercourse with casual partners (CLAI-C) in the last six months, group 
sex with casual partners in the last six months (including “randoms”), taking payment for sex (more 
than six months ago and in the last six months versus never) and sexual sensation-seeking. To assess 
CLAI-C, participants were asked if they had had sex with a casual partner in the previous six months, 
and then six questions about condom use in specific circumstances of positioning (receptive or 
insertive) and ejaculation inside the partner (yes versus no). Responses were then summarised in a 
dichotomous variable which measured any CLAI-C (yes if participants reported not using condoms on 
any of the six questions and no otherwise). Sexual sensation-seeking was measured on an 11-item 
sensation-seeking scale (Kalichman, Heckman, & Kelly, 1996), which assessed the propensity to seek 
out exciting and novel sexual experiences. Each item was measured on a 4-point Likert scale, ranging 
from one (‘not at all like me’) to four (‘very much like me’). Item scores were summed up (range: 11-
44), with higher scores indicating greater sexual sensation-seeking  
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Data analyses 
This analysis includes 1,995 participants who completed the Phase 1 baseline survey and provided 
sufficient data about drug use. The outcome of interest is recent injecting drug use defined as any 
injection drug use in the last six months. We use ‘recent injectors’ to refer to men who reported recent 
injecting and ‘other participants’ to refer to all others, including those who reported never injecting 
and those who had injected more than six months ago. Independent variables included demographic 
characteristics, social factors, drug use factors, sexual practices and other factors described above. 
Associations were initially assessed using Pearson’s 2test for independence. Because the outcome of 
interest – recent injecting drug use - was a binary variable with log-binomial distribution, we used 
log-binomial regression methods with a Type I error of 5%. Variables significantly associated with 
the outcome of interest in unadjusted regression models were included in multivariate analyses. 
Forward step-wise regression was used to successively add groups of related variables to a final 
multivariate model.  
 
Previously White et al. reported an association between dropping out of school and recent drug 
injection (White et al., 2006). We also investigated the interaction of age and education and their 
combined relationship with injecting. For this purpose, a composite variable of age and education was 
created and included in the multiple regression models. Self-reported HIV and HCV status were not 
included in the final regression model due to their correlations with high-risk sexual practices and bi-
directional relationship with the outcome of interest. We report unadjusted and adjusted prevalence 
ratios (PRs) with associated 95% Confidence Intervals (95% CI) for all associations of interest 
examined here. All analyses were conducted in Stata 14.0 (College Station, Texas 77845 USA). 
 
RESULTS  
Between August 2014 and July 2015 2,943 men consented to participate, 2,705 commenced the 
baseline survey and 2,250 fulfilled the minimum data requirements. We excluded 255 participants 
who did not provide sufficient information about drug use. Compared to the 1,995 men included here, 
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the 255 men excluded were older (mean age of 36.1 vs 32.6; p <0.001), more likely to be social 
engaged with gay friends (mean score of 5.6 vs 5.4; p =0.032), more likely to be living with HIV 
(12.9 % vs. 6.9 %; p <0.001) and have greater sexual sensation seeking (mean score of 30.2 vs. 29.0; 
p =0.017), but were otherwise similar.  
 
Most participants (88.6%) identified as gay or homosexual (Table 1). The mean age was 32.6 years 
(SD=12.6, range: 16.5-81) and more than half (52.2%) had completed at least one university degree. 
One in ten men (9.9% of the sample) were unemployed or in receipt of social security, 6.9% self-
reported as living with HIV and 1.9% reported ever being diagnosed with hepatitis C virus (HCV) 
infection. Mean scores on scales of social engagement with gay friends, including those who used 
drugs, were 5.4 (SD=1.7) and 3.8 (SD=2.2). Almost one third (32.3%) spent all or most of their free 
time with gay friends and one in five (19.9%) reported spending all or most of their free time with gay 
friends who use drugs. Just over half (55.8%) met the criteria for depression and 42.5% met the 
criteria for anxiety.  
 
Prevalence of lifetime injecting was 10.3% and prevalence of recent injecting was 4.7% (Table 2). 
Participants who recently injected drugs were more likely than other participants to be older (mean 
age 39.4 vs. 32.3 years; p <0.001) and socially engaged with gay men (mean score of 5.8 vs. 5.4, p 
=0.021) and specifically, gay men who inject drugs (mean score of 5.5 vs. 3.8, p <0.001). Recent 
injectors were more than twice as likely as other participants to report that at least half of their gay 
friends used drugs (67.7% vs. 30.6%, p <0.001). The prevalence of HIV infection among recent 
injectors was almost 10-fold higher than among other participants (46.2% vs. 5.0%, p <0.001). 
[Table 1 & 2 should be near here] 
 
Among men who had ever injected but who had not injected in the last six months, speed was the 
most commonly injected drug (89.0%). Among men who had recently injected drugs, crystal was the 
drug most commonly injected (91.4%). One in six recent injectors (17.2%) reported injecting drugs at 
least weekly and 43.0% at least monthly. Among men who had ever used illicit drugs, participants 
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who had recently injected drugs reported a higher mean number of drugs ever used compared to 
participants who had not injected drugs recently (M=8.0, SD=1.4 vs. M=4.2, SD=2.8, p <0.001). The 
average time since the first use of party drugs was 17.3 years (SD=9.3) for recent injectors and 8.4 
(SD=9.6) for other participants with a history of drug use. Participants who had recently injected 
drugs most commonly reported that they obtained injecting equipment from needle and syringe 
programs (40.9%), sex partners (33.3%) and community pharmacies (31.2%). Almost one in ten 
(8.6%) recent injectors reported receptive syringe sharing (RSS) in the last six months; all but one 
reported always sterilising syringes before re-using them.  
 
Injecting frequently took place in the context of sex with 91.4% of recent injectors reporting injecting 
at least once before or during sex in the last six months. When asked about reasons for crystal use by 
any route of administration, participants who had recently injected were significantly more likely than 
other participants to report using crystal because it would ‘Make it easier for me to get fucked’ 
(31.8% vs. 13.1%, p <0.001), ‘To help me have sex for longer’ (40.0% vs. 19.4%, p <0.001), ‘To 
become less inhibited’ (60.2% vs. 27.1%, p <0.001), ‘For a party and play (PNP) session’ (80.7% vs. 
39.1%, p <0.001) and ‘To party for a long time’ (56.8% vs. 34.8%, p <0.001). When compared with 
men who did not inject drugs in the last six months, significantly fewer participants who recently 
injected drugs reported having one or no sex partners in the last six months (1.1% vs. 32.7%, p 
<0.001) and more reported having ten or more sex partners (57% vs. 24.3%, p <0.001). Similarly, 
practices such as recent group sex (62.4% vs. 23.1%, p <0.001), CLAI-C (73.1% vs. 25.3%, p =0.001) 
and taking payment for sex more than six months ago and in the last six months (28.0% vs. 10.2% and 
14.0% vs. 5.8% respectively; p <0.001) were also more common in men who recently injected drugs 
than men who had not. Finally, levels of sexual sensation-seeking were higher among men who had 
injected recently than among other participants (mean score of 33.4 vs. 28.8, p <0.001). 
[Table 3 should be near here] 
 
Table 4 presents the results of regression analyses. In the final multivariate regression model, factors 
significantly associated with recent injecting were time since initiating party drug use  (APR=1.02, 
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95% CI 1.01-1.04), number of drugs ever used (APR=1.31, 95% CI 1.21-1.41), having multiple sex 
partners (men with 2-10 partners: APR=3.44, 95% CI 1.45-8.20 and >10 partners: APR=3.21, 95% CI 
1.30-7.92 compared with men who had no partners or only one partner), engaging in group sex with 
casual sex partners (APR=1.42, 95% CI 1.05-1.91) and CLAI-C (APR=1.81, 95% CI 1.34-2.43). The 
odds of injecting among GBM men increased 2.0% with each year since initiating party drug use, and 
31.0% with each additional illicit drug ever used.  
 
The sexual sensation-seeking score was associated with injecting in unadjusted analysis (PR=1.06, 
95% CI 1.04-1.08), but was excluded from the final model due to its correlation with the number of 
sex partners. In addition, in bivariate analyses we observed three additional factors that were 
associated with recent injecting: GBM who did not complete high school and who were 31-50 years 
old were more likely to report recent injection drug use than those aged < 30 years (PR=1.54, 95% CI 
1.12-2.11), as were GBM who scored higher on social engagement with gay friends and with gay 
friends who use drugs. However, after adjusting for confounding in the final regression model, these 
factors were no longer associated with recent injecting.  
[Table 4 should be near here] 
 
DISCUSSION 
Prevalence of recent injecting in our study (4.7%) was similar to that reported by GBM in Sydney in 
the 2015 GCPS (4.6%) (Hull et al., 2015). However, both estimates are higher than in the general 
Australian population (0.3%) (Australian Institute of Health and Welfare, 2014).  Injecting was most 
common among recent crystal users (17.2%), a finding similar to that reported by the GCPS. In 
contrast, opioids are the most commonly injected drugs among the predominantly heterosexual 
injectors attending needle and syringe programs (NSP) throughout Australia (Memedovic, Iversen, 
Geddes, & Maher, 2016). However, prevalence of crystal injection among recent injectors in the 
FLUX study was higher than that reported in the 2004-2006 GCPS (91.4% vs 51.8% (Lea, Mao, et al., 
2013) respectively). Although the GCPS did not specifically collect information about crystal 
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injecting after 2006, there was a significant increase in injecting of any drug among crystal users 
during the ten-year period from 2005 to 2014 (from 18.7% to 28.7%; p-trend <0.001) (Lea et al., 
2016).     
 
Prevalence of injecting risk behaviour was high in the current study, with almost one in ten GBM 
reporting RSS in the last six months, but not as high as the 16.0% in the last month reported in the 
2015 Australian Needle and Syringe Program Survey (Memedovic, Iversen, Geddes, & Maher, 2016). 
While NSPs have been operational in Australia since 1987, resulting in high coverage of injections 
with sterile syringes (Iversen, Topp, Wand, & Maher, 2012; Iversen, Linsen, Kwon, & Maher, 2017) 
coverage may be uneven and some groups may experience ongoing barriers to access and availability.  
Encouragingly, some Australian gay community organisations, such as ACON, operate NSPs and 
conduct health promotion activities with a focus on harm reduction and safe injecting practices (AIDS 
Council of New South Wales Inc (ACON), 1991). It is worth noting that nearly all of our participants 
who reported RSS also reported sterilising syringes prior to re-use, potentially indicating a need for 
more precise harm minimisation messages for GBM. Further research is also necessary to explore 
what is meant by sterilisation in this context. 
 
Previous research has suggested that drug use among GBM may be explained by cultural norms 
around sexual relationships and practices which are sustained among socially engaged GBM (Amaro, 
2016; Southgate & Hopwood, 2001). One Australian study (Slavin, 2004a) found that injecting drug 
use fostered a sense of belonging to gay community among some gay men. While men who had 
recently injected in the current study were twice as likely to have gay friends who used drugs, social 
engagement with gay friends, including those who used drugs, was not independently associated with 
recent injecting.  
 
Our participants reported primarily injecting drugs in the context of sex, to enhance sexual pleasure 
and improve sexual performance, a practice described as ‘intensive sex partying’ (Hurley & Prestage, 
2009). Recent injecting was independently associated with having had multiple sex partners, engaging 
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in CLAI-C and group sex with casual partners in the recent six months - practices well known to be 
associated with HIV transmission among GBM (Buchacz et al., 2005; Elford, 2006; Fisher, Reynolds, 
& Napper, 2010; Jin et al., 2009; Prestage, Jin, et al., 2009; Zablotska et al., 2010). Even when 
adjusted for engagement in group sex, men who had multiple sex partners in the preceding six months 
had three times the odds of reporting recent injecting compared to men who had one or no sex 
partners. Men who reported no recent sex and men who reported sex with only one partner (i.e. those 
likely to be in a monogamous relationship) were similar in that neither group tend to be actively 
seeking sex with someone else, and thus were less likely to inject to enhance sexual pleasure. The 
increased likelihood of injecting, particularly in the context of sexual pleasure, suggests the potential 
contribution of injecting, both direct and indirect, via associated sexual practices, to the transmission 
of HIV and HCV among GBM. Exposure to HIV and HCV through condomless anal intercourse, 
particularly with casual partners, may be mediated by sexual disinhibition related to the effects of 
drug, particularly methamphetamine use. Given that the men in our study primarily reported using the 
drugs they injected in order to enhance their sexual experiences they are most likely aware of the 
potentially increased risk this entails.  
 
HIV and HCV prevention interventions for this population need to target GBM who engage in both 
high-risk sexual behaviour and drug injection in the context of sex. For these interventions to be 
successful, a close link to, or the integration of, NSPs into HIV prevention and sexual health services 
for GBM is essential. There is also a need for targeted interventions such as the safe sex party packs 
(consisting of condoms, gloves, silicon lubricant, cock rings, tips and information on how to make 
partying safe and fun, and emergency contact numbers) distributed by ACON in NSW designed for 
men who are planning sex parties. While the integration of NSP into sex party outreach work may 
also be a useful strategy, there is also a need for mainstream NSPs to better meet the needs of GBM 
who inject drugs. Ideally this should be informed by research designed to explore the knowledge and 
practices of GBM who inject drugs and how they manage injection-related harm reduction in sexual 
contexts.  
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Our findings are consistent with, and expand on, those from previous research among GBM who use 
drugs in Australia (Van de Ven, Kippax, Crawford, & Rodden, 1999) and help to identify an 
important target population for harm reduction and health promotion interventions. A related 
publication from the Flux study which compared GBM who reported concurrent use of 
methamphetamine, Truvada and Viagra (MTV) with those who reported methamphetamine and 
Viagra, but not PrEP, found that MTV use was associated with higher risk sexual practices and 
greater social connections with gay community. While this work illustrates the complex negotiations 
between attempts to simultaneously reduce HIV risk and enhance sexual pleasure within gay sexual 
subcultures, it also highlights the need for harm reduction initiatives targeting GBM who engage in 
intensive sex partying (Hammoud et al., submitted). In relation to injecting drug use, we found that 
GBM with longer histories of party drug use and those who reported using a greater number of drugs 
over the lifetime were more likely to be recent injectors. Little is known about transitions from non-
injecting to injecting routes of administration and the drivers and circumstances surrounding the 
initiation of injection among GBM. In the absence of this information and the lack of evidence-based 
interventions designed to prevent transitions to injecting by drug users, identifying GBM at risk of 
injection and preventing transitions remains ethically and empirically fraught (Swift, Maher, & 
Sunjic, 1999). It is therefore important that GBM who are transitioning to injecting drug use are 
equipped with accurate information to ensure initiation into safe injecting practices. 
 
Our analysis also revealed that GBM who did not complete high school and were 31-50 years old 
were more likely to report recent injecting compared to those who completed high-school. This 
finding is consistent with previous studies which have reported strong associations between dropping 
out of school and injecting drug use (White et al., 2006). The data presented here suggest a need to 
identify appropriate mechanisms and target this group of GBM with interventions promoting safer sex 
and injecting practices.  
 
Our study has limitations. Data were self-reported and vulnerable to misreporting and social-
desirability bias. Missing responses to some questions of interest limited our analysis – for example, 
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missing data on the sexual sensation seeking scale (> 10%) precluded the investigation of sensation 
seeking in multivariate analyses. There is also the possibility of recall bias, which we tried to limit by 
restricting our outcome to injecting in the last six months. Our comparison using a dichotomous 
variable of recent injectors versus others possibly resulted in underestimated associations of interest. 
Despite these limitations, the data presented here are valuable because they come from the first study 
in Australia to recruit a cohort of GBM entirely online to focus on drug use. The online space creates 
comfortable conditions for participants to disclose drug use in the context of sex without judgement. 
And while online enrolment might have not reached GBM who do not use the internet, potentially 
threatening external validity, the characteristics of our sample are similar to samples of Australian 
GBM recruited by time-location sampling and therefore valid for comparisons with, and generalisable 
to, socially engaged GBM (Lea, Prestage, et al., 2013; Prestage, Jin, et al., 2009; Zablotska, Holt, & 
Prestage, 2012).  
 
CONCLUSIONS 
Our findings confirm that the prevalence of lifetime injecting drug use among Australian GBM 
(10.3%) is high, with 4.7% reporting injecting in the last six months. Recent injecting was 
independently associated with high-risk sexual practices such as having multiple sex partners, having 
group sex with casual partners and recent CLAI-C. While in the Australian context, unsafe sexual 
practices are the major contributor to HIV transmission among GBM, the potential contribution of 
injection drug use to unsafe sexual practices that drive transmission should not be overlooked. Our 
data suggest a need for interventions targeting GBM who inject drugs to enhance sexual pleasure and 
performance and engage in high-risk sexual behaviour. These results highlight the synergies between 
injecting drug use and high-risk sexual behaviour among GBM, indicating a need for integrated 
combination harm reduction interventions (Burgos et al., 2012; El-Bassel & Strathdee, 2015; 
Strathdee et al., 2013)
 
for GBM who inject methamphetamine in both sexual health services and 
NSPs.  
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Table 1: Characteristics of FLUX study participants at baseline (n=1,995) 
Characteristic Overall 
 
 
 
 
(n= 1,995) 
Did not inject 
drugs in the 
last 6 months  
(Other 
participants) 
(n = 1,902) 
Injected drugs 
in the last 6 
months  
(Recent 
injectors) 
(n = 93) 
Test statistics for 
comparison of 
groups
1
 
(p-value) 
 % % %  
DEMOGRAPHIC FACTORS     
Age     
Mean ± SD
2
 32.6±12.6 32.3 ± 12.6 39.4 ± 10.1 -6.443 (<0.001) 
<30 53.7 55.4 20.4 54.485 (<0.001) 
31-50 34.9 33.2 69.9  
>50 11.3 11.4 9.7  
Education and age
6     
Incomplete HS/TC
3
, 
including: 
24.8 24.3 34.4 24.157 (<0.001) 
- men aged <30 12.8 1.30 8.6  
- men aged 31-50 8.5 7.9 21.5  
- men aged >50 3.5 3.4 4.3  
High school 22.7 23.0 17.2  
Undergraduate  31.2 31.5 24.7  
Post graduate 21 20.9 23.7  
Employment
6
     
FT/PT
4
 employed, 
student 
89.2 89.6 81.7 5.955 (0.051) 
Unemployed/ on social 
security 
9.9 9.5 17.2  
Sexual identification     
Gay/homosexual 88.6 88.5 90.3 0.280 (0.597) 
Other 
5
 11.4 11.5 9.7  
SOCIAL FACTORS     
Social engagement with gay 
friends (scale; 1-9)
6 
    
Mean ± SD 5.4 ± 1.7 5.4
 
± 1.7 5.8 ± 1.7 -2.309 (0.021) 
Proportion of gay friends 
who use drugs 
    
None 24.8 25.7 6.5 57.976 (<0.001) 
A few 42.7 43.5 25.8  
About half and more 32.3 30.6 67.7  
Free time spent with gay 
friend who use drugs  
    
None 41.1 42.6 10.8 50.262 (<0.001) 
A little 38.4 38.0 46.2  
Some/ A lot 19.9 18.8 43.0  
                                                 
1
 We used 2test for independence when comparing sample proportions and t-test when comparing 
means. 
2
 SD – standard deviation 
3
 HS - High school, TC - Trade certificate 
4
 FT – full-time, PT – part-time 
5
 Including men who identified as bisexual 
6 
Less than 1% missing value
 
Table(s)
2 
 
Social engagement with gay 
friends who use drugs (scale; 
1-9)
7 
    
Mean ± SD 3.8 ± 2.2 3.8 ± 2.2 5.5 ± 1.8 -7.787 (<0.001) 
MENTAL HEALTH 
FACTORS 
    
Depression status (based on 
PHQ-9 score)
8 
    
No 44.2 44.6 44.3 0.004 (0.952) 
Yes 55.8 55.4 55.7  
Anxiety status (based on 
GAD-7 score)
8
 
    
No 57.5 54.7 57.4 0.27 (0.603) 
Yes 42.5 45.4 42.6  
OTHER FACTORS     
HIV status     
Negative or unknown 93.1 95.0 53.8 234.218 (<0.001) 
Positive 6.9 5.0 46.2  
Ever diagnosed with 
Hepatitis C virus infection 
    
No 98.1 99.8 85.9 109.195 (<0.001) 
Yes 1.9 1.2 16.1  
Lifetime imprisonment
7
      
No 96.0 98.7 96.8 3.646 (0.162) 
Yes 1.4 1.3 3.2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
1%-5% missing value 
  
8 
5%-10% missing value
 
 
 
3 
 
Table 2: Prevalence of injecting drug use at baseline in the FLUX study (n=1,995) 
 
Name of the drug Never injected Injected more than 6 
months ago 
Injected the drug in 
the last 6 months 
  N (%) N (%) N (%) 
Crystal  1,849 (92.7) 61 (3.1) 85 (4.3) 
Speed 1,885 (94.5) 101 (5.0) 9 (0.5) 
Cocaine 1,947 (97.6) 43 (2.1) 5 (0.3) 
Ketamine 1,960 (98.2) 29 (1.5) 6 (0.3) 
Heroin 1,950 (97.8) 41 (2.1) 4 (0.2) 
Ecstasy 1,950 (97.7) 44 (2.2) 1 (0.1) 
LSD
1
 1,987 (99.6) 7 (0.3) 1 (0.1) 
GHB
2
 1,995 (100) 0 (0.0) 0 (0.0) 
Marijuana 1,995 (100) 0 (0.0) 0 (0.0) 
Amyl 1,995 (100) 0 (0.0) 0 (0.0) 
Any drug 1,789 (89.7) 113 (5.6) 93 (4.7) 
 
 
                                                 
1
 Lysergic acid diethylamide 
2
 Gamma-hydroxybutyrate 
4 
 
Table 3: Drug use and sexual risk behaviours at baseline in the FLUX study (n=1995) 
 
 Overall 
 
 
 
 
(n=1995) 
Did not inject 
drugs in the last 6 
months  
(Other 
participants) 
(n = 1902) 
Injected drugs 
in the last 6 
months  
(Recent 
injectors) 
(n = 93) 
Test statistics for 
comparison of 
groups
1
 
(p-value) 
Time since initiating 
party use (years)
3
 
    
Mean ± SD 7.1 ± 9.5 6.5 ± 9.2 17.3 ± 9.3 -10.927 (< 0.001) 
Number of illicit drugs 
ever used 
    
Mean ± SD 3.5 ± 3.2 3.3 ± 3.1 8.0 ± 1.4 -12.68 (<0.001) 
Ever used crystal 
monthly or more 
frequently 
    
No 88.6 91.8 23.7 408.282(<0.001) 
Yes 11.4 8.2 76.3  
Enjoyed being wired 
when party and play in 
the last 6 months 
    
No 77.1 80.6 7.4 278.799 (<0.001) 
Yes 22.9 19.4 93.6  
Number of sex partners 
in the last 6 months
4
 
    
0-1 31.2 32.7 1.1 65.173 (<0.001) 
2-10 40.2 40.2 38.7  
More than 10 25.8 24.3 57.0  
Recently in 
relationship with main 
partner 
    
No 64.8 64.6 68.8 0.703 (0.402) 
Yes 35.2 35.4 31.2  
Group sex with casual 
partners in the last 6 
months
4
 
    
 
No 71 72.9 33.3 74.454 (<0.001) 
Yes 24.9 23.1 62.4  
CLAI-C
2
 in the last 6 
months 
    
No 72.5 74.7 26.9 101.691 (<0.001) 
Yes 27.5 25.3 73.1  
Received payment for 
sex
4
 
    
Never  79.6 80.9 53.8 43.620 (<0.001) 
> 6 months ago 11.0 10.2 28.0  
In the last 6 months 6.2 5.8 14.0  
                                                 
1
 We used 2test for independence when comparing sample proportions and t-test when comparing 
means. 
2
 Condomless anal intercourse with casual partners 
3 
Less than 1% missing value 
4 
1%-5% missing value 
  
5 
Sexual sensation-seeking 
(scale; 11-44)
5
 
Mean ± SD 29 ± 6.4 28.8 ± 6.4 33.4 ± 5.4 -6.545 (<0.001)
5
10-15% missing value 
6 
 
Table 4: Relationships between socio-demographic characteristics, drug use and sexual 
behaviour and injecting drug use among FLUX study participants 
 
 row N % reported 
injecting 
drugs  
Unadjusted  
Prevalence Ratio 
(95% CI) 
Adjusted  
Prevalence 
Ratio (95% CI) 
Total sample 1,995 4.7   
DEMOGRAPHIC FACTORS     
Age      
<30 1,072 1.8 1.0  
31-50 697 9.3 2.18 (1.75-2.73)  
>50 226 4.0 1.42 (1.00-2.01)  
Education and age
4     
Incomplete HS/TC
1 
including: 
    
- men aged <30 256 3.1 0.78 (0.55-1.13) 1.52 (0.90-2.58) 
- men aged 31-50 170 11.8 1.54 (1.12-2.11) 1.29 (0.84-2.01) 
- men aged >50 68 5.9 1.06 (0.63–1.78) 1.17 (0.56-2.43) 
High school 453 3.5 0.83 (0.62-1.11) 0.98 (0.64-1.49) 
Undergraduate  622 3.7 0.85 (0.65-1.11) 0.92 (0.63-1.32) 
Post graduate 419 5.3 1.0 1.0 
Employment
1     
FT/PT
2
 employed,  students 
students 
1,780 4.3 1.0  
Unemployment/on social 
security
3
 
197 8.1 1.38 (1.05-1.82)
 
 
SOCIAL FACTORS     
Social engagement with gay 
friends (scale: 1-9)
4
 
 
1,995 
 
4.7 
 
1.07 (1.01-1.13) 
 
0.92 (0.83-1.01) 
Social engagement with gay 
friends who use drugs (scale: 
1-9)
5
 
 
1,995 
 
4.7 
 
1.19 (1.14-1.26) 
 
1.03 (0.95-1.12) 
DRUG USE      
Time since initiating party 
drug use (years)
4
 
 
1,995 
 
4.7 
 
1.04 (1.03-1.05) 
 
1.02 (1.01-1.04) 
Number of drugs ever used (0-
10) 
1,995 4.7 1.34 (1.27-1.42) 1.31 (1.21-1.41) 
SEXUAL BEHAVIOUR     
Number of sex partners in the 
last 6 months
5
 
    
0-1 622 0.2 1.0 1.0 
2-10 801 4.5 3.49 (1.87-6.52) 3.44 (1.45-8.20) 
More than 10 515 10.3 5.37 (2.88-10.02) 3.21 (1.30-7.92) 
Recently in relationship with 
main partner 
    
                                                 
1
 HS - High school, TC - Trade certificate 
2
 FT – full-time, PT – part-time 
3
 Despite of significant association with the outcome of interest, variable was not included in the final 
regression due to early loss of significant in the first step of selected model within the demographic 
factors 
4  
Less than 1% missing value 
5 
1%-5% missing value 
  
7 
 
No 1,292 5.0 1.0  
Yes 703 4.1 0.92 (0.75-1.12)  
Group sex with casual 
partners in the last 6 months
5
 
    
No 1,417 2.2 1.0 1.0 
Yes 497 11.7 2.28 (1.86-2.80) 1.42 (1.05-1.91) 
CLAI-C
1
 in the last 6 months     
No 1,446 1.7 1.0 1.0 
Yes 549 12.4 2.60 (2.12-3.20) 1.81 (1.34-2.43) 
Received payment for sex
2,
 
5
     
Never  1,558 3.2 1.0  
>6 months ago 219 11.9 1.97 (1.54-2.52) 
a
  
In the last 6 months 124 10.5 1.83 (1.33-2.52)  
Sexual sensation-seeking 
(scale: 11-44)
7
 
1,777  4.7 1.06 (1.04-1.08)
b  
MENTAL HEALTH 
FACTORS 
    
Depression status (based on 
PHQ-9 score)
6
 
    
No 805 4.6 1.0  
Yes 1,014 4.5 0.99 (0.81-1.21)  
Anxiety status (based on 
GAD-7 score)
6
 
    
No 1,037 4.5 1.0  
Yes 771 5.1 1.05 (0.86-1.28)  
OTHER FACTORS     
HIV status
3
     
Negative or unknown 1,857 2.7 1.0  
Positive 138 31.2 4.21 (3.28-5.39)
 
 
Ever diagnosed with HCV
3     
No 1,958 4.0 1.0  
Yes 37 40.5 4.54 (2.98-6.91)
 
 
Lifetime imprisonment
2     
No 1,915 4.5 1.0  
Yes 27 11.1 1.61 (0.85-3.03)  
 
 
 
 
 
                                                 
1
 Condomless anal intercourse with casual partners 
2
 Variable was not included in the final regression model due to the interaction with ‘number of sex 
partners’ 
3
 Variable was not included in the final regression model due to bi-directed correlation with the 
outcome of interested 
5 
1%-5% missing value 
  
6  
5%-10% missing value
  
7 
10-15% missing value 
